Enhance your practice with CME and tools that focus on the management of neurological conditions.
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Understanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026 Chicago, Illinois
Tau Therapies and Clinical Translation: Mechanistic Approaches
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
Marwan Sabbagh, MD, FAAN
NPS Agitation: Evidence and Emerging Mechanisms of Management
Amyloid-β Therapies in Practice: Not All Are Created Equal
June 15, 2026
Chicago, Illinois
07:30 AM - 09:00 AM ET
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
Is Friedreich’s Ataxia Developmental or Degenerative?
Arnulf Koeppen, MD
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
Examining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Unpacking the Genetics of Friedreich’s Ataxia
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Advances in Cell-Based Therapy for MS
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.